ABVC BioPharma, Inc. (ABVC) Q3 2024 Earnings
ABVC·Reported November 14, 2024·Before market open
ABVC BioPharma, Inc. reported Q3 2024 revenue of $389.3K. Diluted EPS came in at $-0.02.
Revenue
$389.3K
Diluted EPS
$-0.02
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about ABVC BioPharma, Inc.'s Q3 2024 earnings report.
ABVC BioPharma, Inc. (ABVC) reported Q3 2024 earnings on November 14, 2024 before market open.
ABVC BioPharma, Inc. reported revenue of $389.3K and diluted EPS of $-0.02 for Q3 2024.
You can read the 10-Q periodic report (0001213900-24-097840) directly on SEC EDGAR. The filing index links above go to sec.gov.